Generex Biotechnology Corporation (GNBT) announced today presentation of early results from an efficacy study of an immunotherapeutic in triple negative breast cancer patients from its wholly owned subsidiary, Antigen Express, Inc. The results will be made at the 2012 ASCO (American Society of Clinical Oncology) Breast Cancer Symposium on September 14th. Dr. Elizabeth Mittendorf, the […]